- Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate CancerLeonard P Bokhorst
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
Eur Urol 65:329-36. 2014..Large randomized screening trials provide an estimation of the effect of screening at a population-based level. The effect of screening for individuals, however, is diluted by nonattendance and contamination in the trial arms...
- Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*Leonard P Bokhorst
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
BJU Int 110:1654-60. 2012..In men who have previously had a benign biopsy, the PPV drops considerably, but 20% of the cancers detected still show aggressive characteristics...
- Active surveillance: oncologic outcomeLionne D F Venderbos
Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
Curr Opin Urol 23:268-72. 2013..To give insight into recent literature (during the past 12-18 months) reporting on oncologic outcomes of men on active surveillance...